Peter Lassota
Impact in
- Biotechnology top 2%
- Marine Sponges and Natural Products
- Pharmacology top 10%
- Microbial Natural Products and Biosynthesis
Papers in
-
- Marine Sponges and Natural Products 2
-
- Histone Deacetylase Inhibitors Research 3
- Ubiquitin and proteasome pathways 1
- PI3K/AKT/mTOR signaling in cancer 1
- Cell death mechanisms and regulation 1
- Co-authors
- Raymond J. Andersen (2 shared papers)David E. J. Williams (2 shared papers)Chris M. Ireland (1 shared paper)Louis R. Barrows (1 shared paper)Michael Edler (1 shared paper)Rob van Soest (1 shared paper)Nobuharu Shigematsu (1 shared paper)Kirk R. Gustafson (1 shared paper)
- Journals
- Cancer Research (2 papers)The Journal of Organic Chemistry (1 paper)Biochemical Pharmacology (1 paper)Journal of Medicinal Chemistry (1 paper)Journal of the American Chemical Society (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Peter Lassota
12 papers receiving 855 citations
Peers
Comparison fields: 5 of 66
- Biotechnology 162
- Pharmacology 106
- Molecular Biology 396
- Cancer Research 49
- Oncology 68
Countries citing papers authored by Peter Lassota
This map shows the geographic impact of Peter Lassota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Lassota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Lassota more than expected).
Fields of papers citing papers by Peter Lassota
This network shows the impact of papers produced by Peter Lassota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Lassota. The network helps show where Peter Lassota may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Lassota, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 188 | |
| 2 | 2010 | 136 | |
| 3 | 2004 | 121 | |
| 4 | 2003 | 116 | |
| 5 | 2004 | 79 | |
| 6 | 2002 | 76 | |
| 7 | 2010 | 62 | |
| 8 | 1998 | 54 | |
| 9 | 2004 | 53 | |
| 10 | 2009 | 19 | |
| 11 | 2004 | 3 | |
| 12 | NVP-LBH589, a novel histone deacetylase inhibitor, activates caspase-3 and induces apoptosis of human tumor cells in vivo | 2004 | 2 |
About Peter Lassota
Peter Lassota is a scholar working on Biotechnology, Molecular Biology, Oncology, Cell Biology and Pharmacology, having authored 12 papers that have together received 909 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (3 papers), Marine Sponges and Natural Products (2 papers), Ubiquitin and proteasome pathways (1 paper), PI3K/AKT/mTOR signaling in cancer (1 paper), Microtubule and mitosis dynamics (1 paper), Microbial Natural Products and Biosynthesis (1 paper), Cancer Treatment and Pharmacology (1 paper) and Cell death mechanisms and regulation (1 paper). The work is most often cited by research in Biotechnology (162 citations), Pharmacology (106 citations), Molecular Biology (396 citations), Cancer Research (49 citations) and Oncology (68 citations). Peter Lassota has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Raymond J. Andersen, David E. J. Williams, Chris M. Ireland, Louis R. Barrows, Michael Edler, Rob van Soest, Nobuharu Shigematsu, Kirk R. Gustafson, Tawnya C. McKee and Lewis K. Pannell. Their work appears in journals such as Cancer Research, The Journal of Organic Chemistry, Biochemical Pharmacology, Journal of Medicinal Chemistry and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.